So, CARE Ratings ne Kalpataru ke ₹1,590 Crore ke IPO proceeds par apni report finalize kar di hai. Unhone confirm kiya hai ki company ne ₹1,389.91 Crore use kar liye hain, aur ₹168.77 Crore abhi bhi unutilized hain, as of December 31, 2025.
Sabse solid part yeh hai ki company ne apna ₹1,192.50 Crore ka outstanding borrowings, matlab loan, March 31, 2026 ki deadline se bahut pehle, July 2025 tak clear kar diya hai. Yeh financial discipline ka accha sign hai, guys!
Ab baat karte hain General Corporate Purposes (GCP) ki. Iske liye ₹166.24 Crore subsidiaries mein investment aur working capital ke liye use hue hain. Lekin, report mein ek chota sa 'grill' point hai – GCP funds ki total utilization mein thoda inconsistency dikh raha hai, page 6 aur 7 par figures match nahi ho rahe. Ismein clarity chahiye.
Issue expenses ke liye ₹54.82 Crore use kiye gaye hain, jisme se ₹31.32 Crore abhi final settlement mein hain company aur intermediaries ke beech.
Overall, CARE Ratings ka kehna hai ki funds ka use Offer Document aur SEBI ke rules ke according hi ho raha hai. Early debt repayment bahut positive hai. Ab investors ko bas GCP figures ki clarity aur baki bache hue paison ka deployment dekhna hoga.